Advanced Materials and Drug Delivery
The Advanced Materials and Drug Delivery Cluster Area seeks to create and apply cutting-edge biomaterials for high-impact biomedical applications and to create paradigm-changing approaches and systems for advanced drug delivery.
Novel biomaterials are created to solve critical issues of the field: guide tissue regeneration, design highly selective, robust and biocompatible sensors, and alter surface chemistry to improve tissue/device interfaces. Likewise, we thrive to deliver difficult drugs (proteins, peptides, siRNA, insoluble anticancer drugs, vaccine antigens) in a targeted manner and to hard-to- reach places (cancer cells, brain, eye, lymph nodes) for prolonged periods of time (controlled release) in order to maximize therapeutic efficacy.
Our efforts in biomaterials include designing novel polymer-protein and polymer lipid composites for sensing of influenza virus, prostate cancer antigen and antibiotics. Surface engineering of biomaterials can lead to creation of non-wettable surfaces to control protein and cell adhesion, stem cell culture and differentiation. We blend and modify biocompatible polymers to improve mucoadhesion and stability of entrapped drug molecules. We cross-link phospholipid bilayers and develop lipid-peptide complexes to alter cell processing of biomaterials. We collectively contributed to an extensive toolbox of drug delivery platforms such as mucoadhesive gels, biodegradable implants, multicompartmental polymer nanoparticles, cross-linked liposomes for antigen delivery, and lipoprotein nanodisks. These platform technologies deliver a wide range of drug molecules and vaccine antigens with a focus on large molecule stability and delivery.
Related Press Releases & Articles
- March 20 @ 11:30 am
BI Research Day Registration
Join us for the inaugural BI Research Day and third annual Microposter Session on March 20, 2019.
- January 21, 2019 / Article
S. Schwendeman publishes collaborative research on long-active contraceptive delivery
A new publication from Steve Schwendeman and his collaborators from Georgia Tech appears in Nature Biomedical Engineering and features micro-needle patches for long-acting contraceptive delivery.
- January 10, 2019 / Press Release
Kotov Lab draws inspiration from cartilage to develop new battery technology
Latest research findings from the Kotov lab on new structural batteries that are inspired by cartilage.
- January 3, 2019 / Translational Research
BI Startup Evoq Therapeutics profiled in Crain’s Detroit
Crain’s Detroit features Evoq Therapeutics, a startup company co-founded by James Moon and Anna Schwendeman.
- December 11, 2018 / Award
Maria Fawaz and Minzhi Yu receive AHA Predoctoral Fellowships
Maria Fawaz and Minzhi Yu, both graduate students in Anna Schwendeman’s group, have been awarded predoctoral fellowships from the American Heart Association.
- October 31, 2018 / Article
Recent BI Publications
Recent publications from BI Research Groups
- October 23, 2018 / Article
Call for Nominations for BI Innovator Awards
The Biointerfaces Institute seeks nominations for its inaugural round of BI Innovator Awards.
The goal of the Innovator Award is to recognize faculty, graduate student and postdoctoral researchers who are active contributors to the interdisciplinary research, innovation and translational ecosystem at BI.
- August 21, 2018 / Award
James Moon Earns 2018 AAPS Emerging Leader Award
This award recognizes scientists and pharmaceutical professionals who are early in their careers, who have made a significant impact in the pharmaceutical sciences that promotes public health.
- May 21, 2018 / Award
Chestek, Moon and A. Schwendeman Promoted
Cindy Chestek (Biomedical Engineering), James Moon (Pharmaceutical Sciences) and A. Schwendeman (Pharmaceutical Sciences) were promoted to Associate Professor with tenure. Congratulations!
- May 3, 2018 / Article
Tessier elected to the AIMBE College of Fellows Class of 2018
Peter Tessier was elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). AIMBE comprises of leaders in medical and biological engineering, consisting of academic, industrial, professional society councils and elected fellows.
- May 1, 2018 / Award
Congratulations Microposter Winners
Thank you to all of the poster presenters who attended the BIRG 2nd Microposter Session and congratulations to our winners!
- April 25, 2018 / Award
Kevin Golovin receives ProQuest Distinguished Dissertation Award
The ProQuest Distinguished Dissertation Award recognizes exceptional and unusually interesting work produced by doctoral students from the Rackham School of Graduate Studies.
- April 16, 2018 / YouTube Video
Tuteja lab reports on new omniphobic coatings that repel almost everything
In a paper recently published in ACS Applied Materials & Interfaces, the Tuteja lab reports on recent findings on omniphobic coatings that could be applied on a variety of surfaces to repel almost any liquid.
- April 2, 2018 @ 1:00 pm
Oral PhD Defense – Lukasz Ochyl
Title: “Preparation and Characterization of Cell Membranes for Cancer Immunotherapy”
Lukasz Ochyl, Department of Pharmaceutical Sciences
Chair: James Moon
- March 14, 2018 / Press Release
Press Release – 3D Printing for Medicine
A collaborative project from the Lahann, Luker and Krebsbach labs reports on new jet writing technique for printing 3D structures for biomedical applications.
- March 1, 2018 / Article
Interdisciplinary team of BI researchers publish new article on 3-D Jet Writing Technique
The article entitled “3D Jet Writing: Functional Microtissues Based on Tessellated Scaffold Architectures” appears in Advanced Materials.
- February 22, 2018 @ 2:00 pm
Seminar on “Materials for Biodegradable Electronics” – John Rogers, Northwestern University
This event is co-hosted by the University of Michigan ACS POLY/PMSE Student Chapter and the Biointerfaces Institute Researcher Group.
- February 21, 2018 / YouTube Video
Kotov awarded Gold Prize Award in the Mobile World Scholar Challenge
Nick Kotov’s work on biomimetic composites is recognized by the Mobile World Scholar Challenge
- January 30, 2018 @ 12:00 pm
Marc Thurner, CEO of RegenHu, will be discussing the company’s line of 3D bioprinters.